Upload
sharyl-patrick
View
217
Download
1
Tags:
Embed Size (px)
Citation preview
Dorset Improving Diagnosis of
Heart Failure
Implementation of BNP Measuring in
General Practice
Ist Project Steering Group 13th Sept 2011
Introduction to the BNP Project Introduction to the BNP Project
Dr Christopher Boos Dr Christopher Boos
Consultant CardiologistConsultant Cardiologist
Why Change the Current HF Diagnostic Pathway
HF huge clinical burden – length of stay, admission diagnosis, yet sig proportion not
getting access to specialist input
Prognosis is improving but several aspects of care need to be improved
HCC audit in 2007 reported that the delivery of HF diagnostic services is poor or only
average in 50% of the UK
Health Technology Assessment (HTA) in England - measuring NPs is the single most
useful test to add to the diagnostic process in primary care - Mant J et al 2009
– ‘rule-out’ test in patients with suitable clinical presentation and suspected heart
failure
ESC HF Guidelines 2009
Heart failure is a clinical syndrome in which patients have the
following features:
† Symptoms typical of heart failure
(breathlessness at rest or on exercise, fatigue, tiredness, ankle
swelling)
and
† Signs typical of heart failure
(tachycardia, tachypnoea, pulmonary rales, pleural effusion, raised
jugular venous pressure, peripheral oedema, hepatomegaly)
and
† Objective evidence of a structural or functional
abnormality of the heart at rest
(cardiomegaly, third heart sound, cardiac murmurs, abnormality on
the echocardiogram, raised natriuretic peptide concentration
Why Change the Current HF Diagnostic Pathway
Discovery interviews (Dec 2010) – integrated care pathway for HF and
improve diagnosis – adopt BNP use into the diagnostic pathway
Recent process mapping of HF patient pathways - huge variation in service
provision and time to HF diagnosis across Dorset. GP ? HF patient might be
referred for
– blood tests then wait results then refer
– One stop echo, breathlessness clinic
– Cardiology Outpatients (Cardiologist may do echo upstream or
downstream)
Why Change the Current HF Diagnostic Pathway
BNP only in RBCH breathless clinic
Previously DCH - useful but stopped (funding, economies of scale)
Huge variation in Echo waits across Dorset
– median of 5 -7 weeks wait for echo
Difficulty in HF diagnosis (HFNEF/HFPEF)
Under diagnosis
Echo Pathway Audit Data – need for improved efficiency
Audit Sept 2011Audited last 66 one stop echo clinic referrals to AAM
40 with ? Heart failure
52.5% male, mean age 72.2 years
LV systolic dysfunction (EF<55%)
– 3 / 40 (7.5%)
HFNEF
– 3 / 40 (7.5%) – one with HCM and sig diastolic dysfunction
Any HF
– 6/40 (15%) had diagnosis compatible with HF
Other tests
FBC Renal LFTS TFTS Glucose CXR
35/39 35/39 34/39 20/39 32/39 25/39
Advantages of BNP
V Good rule out test
Raised level does not diagnose HF
Absolute levels carry prognostic importance
– Very high levels carry a poor prognosis
HFNEF vs HF reduced EF
– the level does not differentiate but can be helpful
Disadvantages of BNPCertain conditions can Reduce BNP
– Obesity
– Drugs - diuretics, ACE inhibitors, beta-blockers, ARBs and aldosterone antagonists
Certain Conditions increase BNP
– LVH
– Ischaemia
– Right ventricular overload and hypoxaemia (including PE)
– GFR < 60 ml/minute
– Sepsis
– COPD, Diabetes and liver cirrhosis
– Increasing age particularly > 70
Action Planning Form Dorset Specific HF pathway - BNP central to this
– BNP in Primary care only, secondary care ambition
– Education ++ Gps, secondary care
– Identify and agree central laboratory / Assay (NT-proBNP)
Diagnostic Cut offs?
– <70 100pg/mL and >70 300pg/mL
– Sample processing and information passage etc
– 24 PARADIGM pts mean 539 pg/mL; median 289 pg/mL 4/24 <100 (16%)
Secondary care trusts planning for delivery of time lines
– 2 week and 6 week time points
– Specialist assessment